Skip to content

UROLIFT IPN929207Recalls & reported problems

Teleflex Incorporated · UroLift UL2 ATC Implant Cartridge · Class 2 · Implant

All models of UROLIFT (13)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 10814932020459), received between Dec 5, 2024 and Sep 9, 2026 — classified as 2 injuries, 2 malfunctions.

The most frequently reported specific device problem is “Firing Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 2 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 1 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Firing Problem1
  • Material Rupture1

Patient problems

  • Hematuria2
  • Urinary Retention2
  • No Clinical Signs, Symptoms or Conditions1
  • Skin Inflammation/ Irritation1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 9, 2026Firing Problem

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50690138 ↗
  • MalfunctionNov 19, 2025Material Rupture; Material Rupture

    IT WAS REPORTED " NOTICED THROUGHOUT THE PROCEDURE CARTRIDGES WERE SLIGHTLY MORE DIFFICULT TO INSERT BUT STILL SEEMED TO BE LOCKING IN PROPERLY. BEFORE PLACING THE 6TH IMPLANT, THE DELIVERY SYSTEM NEEDED TO BE RESET. IT SEEMED LIKE THE TRIGGER HADN'T BEEN FULLY RETRACTED AFTER LAST IMPLANT DELIVERY. PHYSICIAN SUCCESSFULLY INSERTED ATC CARTRIDGE INTO DELIVERY SYSTEM AND ATTEMPTED PLACEMENT ON PATIENTS LEFT PROXIMAL SLIGHTLY ANTERIOR TO FIRST PROXIMAL IMPLANT. AFTER RETRACTING NEEDLE/3RD PULL THE KEYHOLE SHOWED METAL THAT LOOKED LIKE THE NEEDLE, NOT A CT OR UE. SUCCESSFULLY REMOVED DELIVERY SYSTEM BUT THE TIP OF DELIVERY SYSTEM SHOWED THE NEEDLE WAS BROKEN IN HALF. WE USED VO TO LOOK INSIDE PATIENT AND SAW NEEDLE TIP FLOATING AT THE BASE OF THE BLADDER. PHYSICIAN USED A GRASPER TO REMOVE TIP OF NEEDLE THROUGH RIGID CYSTO SHEATH. PATIENT HAD SOME IRRITATION TO THE BLADDER WALL FROM NEEDLE WHICH RESULTED IN PLACEMENT OF A CATHETER. PATIENT HAD CATHETER REMOVED NEXT DAY AND DOES NOT REPORT ANY ADDITIONAL CONCERNS".

    Patient problems: Skin Inflammation/ Irritation

    MAUDE report 23594425 ↗
  • InjuryDec 5, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON (B)(6) 2024, NEOTRACT HAS BEEN MADE AWARE BY A [PHYSICIAN] THAT ¿TWO PATIENTS WHO UNDERWENT THE PROSTATIC URETHRAL LIFT (PUL) PROCEDURE ON (B)(6) 2024, REQUIRED READMISSION TO THE HOSPITAL DUE TO HEMATURIA AND CLOT RETENTION. ACCORDING TO [PHYSICIAN], ONE PATIENT REQUIRED A RETURN TO THE OPERATING ROOM FOR CLOT EVACUATION. [PHYSICIAN] NOTED THAT BLEEDING EVENTS OF THIS NATURE ARE NOT UNCOMMON FOLLOWING BENIGN PROSTATIC HYPERPLASIA (BPH) PROCEDURES.¿ ON (B)(6) 2024, A LABEL PHOTO OF THE DEVICE WAS PROVIDED. ADDITIONAL INFORMATION RECEIVED ON NOVEMBER 12, 2024, INDICATED THAT FOUR HOURS AFTER UNDERGOING THE UROLIFT PROCEDURE, THE PATIENT EXPERIENCED HEMATURIA AND CLOT RETENTION. THE PATIENT WAS ALREADY ADMITTED TO THE HOSPITAL AT THE TIME AND UNDERWENT SURGICAL INTERVENTION TO REMOVE THE CLOTS. THE PATIENT¿S CONDITION WAS REPORTED TO BE FINE FOLLOWING THE PROCEDURE. THE FACILITY ADDRESS, DEVICE LOT NUMBER, AND PHYSICIAN CONTACT INFORMATION WERE ALSO PROVIDED.

    Patient problems: Hematuria; Urinary Retention

    MAUDE report 20850557 ↗
  • InjuryDec 5, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON (B)(6) 2024, NEOTRACT HAS BEEN MADE AWARE BY A [PHYSICIAN] THAT ¿TWO PATIENTS WHO UNDERWENT THE PROSTATIC URETHRAL LIFT (PUL) PROCEDURE ON OCTOBER 31, 2024, REQUIRED READMISSION TO THE HOSPITAL DUE TO HEMATURIA AND CLOT RETENTION. ACCORDING TO [PHYSICIAN], ONE PATIENT REQUIRED A RETURN TO THE OPERATING ROOM FOR CLOT EVACUATION. [PHYSICIAN] NOTED THAT BLEEDING EVENTS OF THIS NATURE ARE NOT UNCOMMON FOLLOWING BENIGN PROSTATIC HYPERPLASIA (BPH) PROCEDURES.¿ ON (B)(6) 2024, A LABEL PHOTO OF THE DEVICE WAS PROVIDED. ADDITIONAL INFORMATION RECEIVED ON NOVEMBER 12, 2024, INDICATED THAT ONE OF THE PATIENTS EXPERIENCED HEMATURIA AND CLOT RETENTION IN THE EVENING FOLLOWING THE UROLIFT PROCEDURE. THE PATIENT HAD ALREADY BEEN ADMITTED TO THE HOSPITAL AT THAT TIME AND UNDERWENT CLOT EVACUATION SURGERY. POST-SURGERY, THE PATIENT WAS REPORTED TO BE FINE. THE FACILITY ADDRESS, DEVICE LOT NUMBER, AND PHYSICIAN CONTACT INFORMATION WERE ALSO PROVIDED.

    Patient problems: Hematuria; Urinary Retention

    MAUDE report 20850547 ↗

Other Implantable transprostatic tissue retractor system devices

All Implantable transprostatic tissue retractor system devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page